Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase NA 6Phase 3 5Phase 1/2 3Phase 4 2Phase 2/3 2Phase 1 2Phase EARLY_PHASE1 1

Status

Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Gastrointestinal 1CNS 1Breast 1

Conditions

Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Medulloblastoma 1Leukemia, Myeloid, Acute 1Leiomyosarcoma 1HER2 IHC3+ Advanced Colorectal Cancer 1Cognitive Dysfunction 1Breast Neoplasms 1

Interventions

pembrolizumab 222Carboplatin 215Cisplatin 203Paclitaxel 181Gemcitabine 148Docetaxel 126Capecitabine 114Cyclophosphamide 102Pemetrexed 100Dexamethasone 100Specimen Handling 99Magnetic Resonance Spectroscopy 97Oxaliplatin 96Radiotherapy 94Doxorubicin 91Fluorouracil 88Bevacizumab 84Leucovorin 73Nivolumab 72Rituximab 71Vincristine 68durvalumab 65Lenalidomide 64Radiation 62atezolizumab 61Irinotecan 61Etoposide 60130-nm albumin-bound paclitaxel 58Prednisone 55Letrozole 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Tablets × 1 year × Clear all
NCT04055493 2026-05-11

ADAPTcycle

West German Study Group

Phase 3 Active not recruiting
1,684 enrolled
Breast

Breast Neoplasms

NCT05907057 2026-05-08

An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.

Servier

Phase 3 Recruiting
245 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05230758 2026-05-01

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting
140 enrolled
CNS

Medulloblastoma, Cognitive Dysfunction

NCT07483684 2026-03-19

A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 3 Not yet recruiting
142 enrolled
Gastrointestinal

HER2 IHC3+ Advanced Colorectal Cancer

NCT03016819 2026-02-25

APROMISS

Advenchen Laboratories, LLC

Phase 3 Recruiting
325 enrolled
Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡